Pyxis Oncology (PYXS) Capital Expenditures (2020 - 2024)
Pyxis Oncology (PYXS) reported Capital Expenditures of $237000.0 for Q1 2024, down 94.62% year-over-year from $4.4 million in Q2 2023, and up 288.52% quarter-over-quarter from $61000.0 in Q3 2023.
Pyxis Oncology (PYXS) Capital Expenditures (2020 - 2024) Analysis & Trends
Pyxis Oncology (PYXS) has 5 years of Capital Expenditures data on file, last reported at $237000.0 in Q1 2024.
- Capital Expenditures for Q1 2024 came in at $237000.0, down 94.62% year-over-year; the trailing twelve-month figure through Dec 2024 was $237000.0 (down 96.48% YoY), and the FY2025 annual result was $9000.0, down 96.2% from the prior year.
- Capital Expenditures improved to $237000.0 in Q1 2024 per PYXS's latest filing, from $61000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $4.4 million in Q1 2023 and troughed at -$1.5 million in Q4 2020.
- A 5-year average of $957000.0 and a median of $237000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures jumped 2917.81% in 2023, then slumped 94.62% in 2024.
- A 5-year view of Capital Expenditures shows it stood at -$1.5 million in 2020, then jumped by 125.5% to $371000.0 in 2021, then jumped by 740.7% to $3.1 million in 2022, then slumped by 98.04% to $61000.0 in 2023, then jumped by 288.52% to $237000.0 in 2024.
- Business Quant data shows PYXS's Capital Expenditures at $237000.0 in Q1 2024, $61000.0 in Q3 2023, and $2.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 237,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 2.26 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | 3.12 Mn |
| Dec 31, 2022 | 3.12 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | 146,000.00 |
| Mar 31, 2022 | 146,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Mar 31, 2021 | 169,000.00 |
| Mar 31, 2021 | 169,000.00 |